Document:

REGISTRATION
RIGHTS AGREEMENT

THIS
REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of September 21, 2021, by and among
Clinigence Holdings, Inc., a Delaware corporation (the “Company”), and Apollo Medical Holdings, Inc., a Delaware corporation
(“Purchaser”).

BACKGROUND
STATEMENT

This
Agreement is made pursuant to that certain Securities Purchase Agreement dated as of the date hereof between Company and Purchaser (the
“Securities Purchase Agreement”).

AGREEMENT

NOW,
THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, and in order to induce Purchaser to enter into the Stock Purchase Agreement, the
parties hereto hereby agree as follows:

1. Defined
Terms. Capitalized terms used and not otherwise defined herein shall have

the
meanings given such terms in the Securities Purchase Agreement. As used in this Agreement, the following terms shall have the following
respective meanings:

“Advice”
shall have the meaning set forth in Section 7(b).

“Affiliate”
means, as to any Person, (i) any other Person which directly, or indirectly through one or more intermediaries, controls such Person
or is consolidated with such Person in accordance with generally accepted accounting principles, (ii) any other Person which directly,
or indirectly through one or more intermediaries, is controlled by or is under common control with such Person, or (iii) any other Person
of which such Person owns, directly or indirectly, ten percent (10%) or more of the common stock or equivalent equity interests. As used
herein, the term “control” means possession, directly or indirectly, of the power to direct or cause the direction of the
management or policies of a Person, whether through the ownership of voting securities or otherwise.

“Agreement”
shall have the meaning set forth in the Preamble.

“Allowable
Grace Period” shall have the meaning set forth in Section 2(d).

“Business
Day” means any day of the year on which banks are open for business in Los Angeles, California.

“Commission”
means the Securities and Exchange Commission.

“Company” shall have the meaning set forth in the Preamble.

“Effective
Date” means the date that the Registration Statement filed pursuant to Section 2(a) is first declared effective by the
Commission.

“Effectiveness
Period” shall have the meaning set forth in Section 2(b).

“Filing
Deadline” means, with respect to the Initial Registration Statement required to be filed pursuant to Section 2(a), the Trading
Day immediately following the earlier of (i) the expiration of the Warrants in accordance with its terms and (ii) twelve (12) months
after the Warrants are exercised in full, provided, that if the Filing Deadline falls on a Saturday, Sunday or other day that the Commission
is closed for business, the Filing Deadline shall be extended to the next business day on which the Commission is open for business.

“FINRA”
shall have the meaning set forth in Section 3(g). “Grace Period” shall have the meaning set forth in Section
2(d).

“Holder”
or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

“Indemnified
Party” shall have the meaning set forth in Section 5(c). “Indemnifying Party” shall have the meaning
set forth in Section 5(c).

“Initial
Registration Statement” means the initial Registration Statement filed pursuant to Section 2(a) of this Agreement.

“Losses”
shall have the meaning set forth in Section 5(a).

“New
Registration Statement” shall have the meaning set forth in Section 2(a).

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such
as a deposition), whether commenced or threatened.

“Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under
the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion
of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including
post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

“Registrable
Securities” means (1) any shares of Common Stock issued by the Company at any time or from time to time pursuant to the Securities
Purchase Agreement, (2) any Warrant Shares issued by the Company upon exercise of the Warrants, and (3) any additional shares of Common
Stock or other equity securities of the Company issued by the Company in respect of the shares of Common Stock and/or Warrant Shares
described in the foregoing subclauses (1) and (2) after the issuance of such shares of Common Stock or Warrant Shares, as applicable,
in connection with a stock dividend, stock split, combination, exchange, reorganization, recapitalization or similar reclassification
of the Company’s securities; provided, that, as to any particular Registrable Securities, such securities shall cease to
constitute Registrable Securities when: (x) a registration statement with respect to the sale of such securities shall have become effective
under the Securities Act and such securities shall have been disposed of thereunder; (y) such securities shall be able to be sold in
satisfaction of all applicable conditions to the resale provisions of Rule 144 under the Securities Act (or any similar provision then
in force); or (z) such securities shall have ceased to be issued and outstanding.

“Registration
Statements” means any one or more registration statements of the Company filed under the Securities Act that covers the resale
of any of the Registrable Securities pursuant to the provisions of this Agreement (including without limitation the Initial Registration
Statement, the New Registration Statement and any Remainder Registration Statements), amendments and supplements to such Registration
Statements, including post-effective amendments.

“Remainder
Registration Statement” shall have the meaning set forth in Section 2(a).

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to
time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

“Rule
415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to
time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

“Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to
time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

“SEC
Guidance” means (i) any publicly-available guidance, comments or requirements of the Commission staff and (ii) the Securities
Act.

“Securities
Purchase Agreement” shall have the meaning set forth in the Recitals.

“Selling
Shareholder Questionnaire” means a questionnaire in the form adopted by the Company from time to time.

“Trading
Market” means the NASDAQ Capital Market or other exchange, trading market or quotation system on which the Common Stock is
listed or quoted for trading on the date in question.

2. Registration.

(a)On
or prior to the Filing Deadline, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities not already covered by an existing and effective Registration Statement for an offering to be made
on a continuous basis pursuant to Rule 415 or, if Rule 415 is not available for offers and sales of the Registrable Securities, by such
other means of distribution of Registrable Securities as the Company may reasonably determine (the “Initial Registration Statement”).
The Initial Registration Statement shall be on Form S-3 (except if the Company is then ineligible to register for resale of the Registrable
Securities on Form S-3, then the Initial Registration Statement shall be on Form S-1). Subject to such other limitations as specified
in this Agreement, the Company shall have the right to include its equity securities that are not Registrable Securities, including a
primary offering of equity securities by the Company for its own account or a secondary offering of equity securities owned by the Company’s
directors and officers, in any such Registration Statement. Notwithstanding the registration obligations set forth in this Section 2,
in the event the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule
415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly (i) inform each
of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration Statement as required
by the Commission, (ii) remove any and all securities that are not Registrable Securities from such Initial Registration Statement and/or
(iii) withdraw the Initial Registration Statement and file a new registration statement (a “New Registration Statement”),
in either case covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form S-3 or such
other form available to the Company to register for resale the Registrable Securities as a secondary offering; provided, that
prior to filing such amendment or New Registration Statement, the Company shall be obligated to use its commercially reasonable efforts
to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the SEC Guidance. In the
event the Company amends the Initial Registration Statement or files a New Registration Statement, as the case may be, under clauses
(i) or (ii) above, the Company will use its commercially reasonable efforts to file with the Commission, as promptly as allowed by Commission
or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or
such other form available to the Company to register for resale those Registrable Securities that were not registered for resale on the
Initial Registration Statement, as amended, or the New Registration Statement (the “Remainder Registration Statements”).

(b) 
The Company shall use its commercially reasonable efforts to cause each Registration Statement to be declared effective by the Commission
as soon as practicable (and will continue to use commercially reasonable efforts thereafter if the applicable Registration Statement
is not effective by such date), and shall use its commercially reasonable efforts to keep each Registration Statement continuously effective
under the Securities Act until the earlier of (i) such time as all of the Registrable Securities covered by such Registration Statement
have been publicly sold by the Holders or (ii) the date that all Registrable Securities covered by such Registration Statement may be
sold by Holders under Rule 144, and without the requirement for the Company to be in compliance with the current public information requirements
under Rule 144(c)(1) (or Rule 144(i)(2), if applicable), as determined by counsel to the Company pursuant to a written opinion letter
to such effect, addressed and reasonably acceptable to the Company’s transfer agent and the affected Holders (the “Effectiveness
Period”).

(c) 
Each Holder agrees to furnish to the Company a completed Selling Shareholder Questionnaire not more than seven (7) Trading Days following
the date of the Company’s written request therefor. At least five (5) Trading Days prior to the first anticipated filing date of
a Registration Statement for any registration under this Agreement, the Company will notify each Holder of the information the Company
requires from that Holder other than the information contained in the Selling Shareholder Questionnaire, if any, which shall be completed
and delivered to the Company promptly upon request and, in any event, within three (3) Trading Days prior to the applicable anticipated
filing date. Each Holder further agrees that it shall not be entitled to be named as a selling security holder in the Registration Statement
or use the Prospectus for offers and resales of Registrable Securities at any time, unless such Holder has returned to the Company a
completed and signed Selling Shareholder Questionnaire and a response to any requests for further information as described in the previous
sentence. If a Holder of Registrable Securities returns a Selling Shareholder Questionnaire or a request for further information, in
either case, after its respective deadline, the Company shall use its commercially reasonable efforts at the expense of the Holder who
failed to return the Selling Shareholder Questionnaire or to respond for further information to take such actions as are required to
name such Holder as a selling security holder in the Registration Statement or any pre-effective or post-effective amendment thereto
and to include (to the extent not theretofore included) in the Registration Statement the Registrable Securities identified in such late
Selling Shareholder Questionnaire or request for further information. Each Holder acknowledges and agrees that the information in the
Selling Shareholder Questionnaire or request for further information as described in this Section 2(c) will be used by the Company
in the preparation of the Registration Statement and hereby consents to the inclusion of such information in the Registration Statement.

(d) 
Notwithstanding anything to the contrary herein, at any time after the Registration Statement has been declared effective by the Commission,
the Company may delay the disclosure of material non-public information concerning the Company if the disclosure of such information
at the time is not, in the good faith judgment of the Company, in the best interests of the Company (such delay, a “Grace Period”);
provided, the Company shall promptly (i) notify the Holders in writing of the existence of material non-public information giving
rise to a Grace Period (provided that the Company shall not disclose the content of such material non-public information to the Holders)
or the need to file a post-effective amendment, as applicable, and the date on which such Grace Period will begin, (ii) use commercially
reasonable efforts to terminate a Grace Period as promptly as reasonably practicable, unless doing so would reasonably be expected to
have a material adverse effect on the Company with respect to any proposal or plan of the Company to effect a merger, acquisition, disposition,
financing, reorganization, recapitalization or similar transaction or any negotiations, discussions or pending proposals with respect
thereto, and (iii) notify the Holders in writing of the date on which the Grace Period ends; provided, further, that no
single Grace Period shall exceed one hundred twenty (120) consecutive days, and during any three hundred sixty-five (365) day period,
the aggregate of all Grace Periods shall not exceed an aggregate of two hundred ten (210) days (each Grace Period complying with this
provision being an “Allowable Grace Period”). For purposes of determining the length of a Grace Period, the Grace
Period shall be deemed to begin on and include the date the Holders receive the notice referred to in clause (i) above and shall end
on and include the later of the date the Holders receive the notice referred to in clause (iii) above and the date referred to in such
notice; provided, that no Grace Period shall be longer than an Allowable Grace Period.

(e) 
Holder Piggyback Rights. If, at any time during the Effectiveness Period but in no event earlier than the six (6) month anniversary
of the date of this Agreement, there is not an effective Registration Statement covering all of the Registrable Securities and the Company
shall determine to prepare and file with the Commission a registration statement relating to an offering for its own account or the account
of others under the Securities Act of any of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the
Securities Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any
entity or business or equity securities issuable in connection with the Company’s stock option or other employee benefit plans,
then the Company shall deliver to each Holder a written notice of such determination and, if within fifteen (15) days after the date
of the delivery of such notice, at least 85% in interest of the Holders so request in writing, the Company shall include in such registration
statement all or any part of such Registrable Securities such Holders request to be registered; provided, however, that the Company shall
not be required to register any Registrable Securities pursuant to this Section 2(e) that are eligible for resale pursuant to
Rule 144 (without volume restrictions or current public information requirements) promulgated by the Commission pursuant to the Securities
Act, that are the subject of a then effective Registration Statement or that are subject to the limitations set forth in Section 3(l)
below.

3. Registration
Procedures

In
connection with the Company’s registration obligations hereunder:

(a) 
(i) the Company shall prepare and file with the Commission such amendments, including post-effective amendments and supplements, to each
Registration Statement and the Prospectus used in connection therewith as may be necessary to keep such Registration Statement continuously
effective as to the applicable Registrable Securities for its Effectiveness Period (except during an Allowable Grace Period); (ii) the
Company shall cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms
of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424 (except during an Allowable Grace Period); (iii)
the Company shall respond as promptly as reasonably practicable to any comments received from the Commission with respect to each Registration
Statement or any amendment thereto; and (iv) the Company shall comply with the provisions of the Securities Act and the Exchange Act
with respect to the disposition of all Registrable Securities covered by a Registration Statement until such time as all of such Registrable
Securities shall have been disposed of (subject to the terms of this Agreement) in accordance with the intended methods of disposition
by the Holders thereof as set forth in such Registration Statement as so amended or in such Prospectus as so supplemented; provided,
that Purchaser shall be responsible for the delivery of the Prospectus to the Persons to whom such Purchaser sells any of the Registrable
Securities (including in accordance with Rule 172 under the Securities Act), and Purchaser agrees (and shall cause each other Holder)
to dispose of Registrable Securities in compliance with the plan of distribution described in the Registration Statement and otherwise
in compliance with applicable federal and state securities laws. In the case of amendments and supplements to a Registration Statement
which are required to be filed pursuant to this Agreement (including pursuant to this Section 3(a)) by reason of the Company filing
a report on Form 10-K, Form 10-Q or Form 8-K or any analogous report under the Exchange Act, the Company shall have incorporated such
report by reference into such Registration Statement, if applicable or permissible, or shall file such amendments or supplements with
the Commission as soon as reasonably practicable after the Exchange Act report which created the requirement for the Company to amend
or supplement such Registration Statement was filed.

(b) 
the Company shall use commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order
suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification)
of any of the Registrable Securities for sale in any jurisdiction, as soon as practicable.

(c) 
the Company shall, if requested by a Holder, furnish to such Holder, without charge, at least one conformed copy of each Registration
Statement and each amendment thereto and all exhibits to the extent requested by such Holder promptly after the filing of such documents
with the Commission; provided, that the Company may provide a link to, and shall have no obligation to provide a physical copy
of, any such document that is available on the Commission’s EDGAR or successor system.

(d) 
the Company shall, prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or
qualify or cooperate with the selling Holders in connection with the registration or qualification (or exemption from the registration
or qualification) of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions
within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom)
effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in
such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that the Company shall not
be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any material
tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such jurisdiction.

(e) 
the Company shall, reasonably cooperate with the Holders to facilitate the timely preparation and delivery of certificates representing
Registrable Securities to be delivered to a transferee pursuant to the Registration Statement, which certificates shall be free, to the
extent permitted by the Securities Purchase Agreement and under law, of all restrictive legends, and to enable such Registrable Securities
to be in such denominations and registered in such names as any such Holders may reasonably request. Certificates for Registrable Securities
free from all restrictive legends may be transmitted by the transfer agent to a Holder by crediting the account of such Holder’s
prime broker with DTC as directed by such Holder.

(f) 
subject to Section 2(c), the Company shall, following the occurrence of any event that the Company determines requires it to file
a supplement or amendment to any Registration Statement, as promptly as reasonably practicable (taking into account the Company’s
good faith assessment of any adverse consequences to the Company and its shareholders of the premature disclosure of such event), prepare
and file a supplement or amendment, including a post-effective amendment, to the affected Registration Statements or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain an untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus,
form of prospectus or supplement thereto, in light of the circumstances under which they were made), not misleading.

(g) 
the Company may require each selling Holder to furnish to the Company a certified statement as to (i) the number of Securities beneficially
owned by such Holder and any Affiliate thereof, (ii) any Financial Industry Regulatory Authority (“FINRA”) affiliations,
(iii) any natural persons who have the power to vote or dispose of the Common Stock and (iv) any other information as may be requested
by the Commission, FINRA, any state securities commission or any other government or regulatory body with jurisdiction over the Company
or its activities.

(h) 
the Company shall cooperate with any registered broker through which a Holder proposes to resell its Registrable Securities in effecting
a filing with FINRA pursuant to FINRA Rule 5110 as requested by any such Holder..

(i) 
as and when Form S-3 is available to the Company, the Company shall use its commercially reasonable efforts to maintain or achieve eligibility
for use of Form S-3 (or any successor form thereto) for the registration of the resale of Registrable Securities.

(j) 
[Intentionally omitted.]

(k) 
if the managing underwriter(s) of a proposed underwritten offering of Registrable Securities effected pursuant to Section 2(a) advise
the Holders requesting to sell Registrable Securities in such underwritten offering in writing that, in their opinion, the number of
securities requested to be included in such offering exceeds the number which can be sold in such offering without being likely to have
a significant adverse effect on the price, timing or distribution of the securities offered or the market for the securities offered,
the securities to be included in such Registration Statement (i) first, shall be allocated, pro rata if necessary, among the Holders
that have requested to sell Registrable Securities in such underwritten offering, (ii) second, and only if all the securities referred
to in clause (i) have been included in such Registration Statement, shall be allocated to any shares that the Company has requested to
sell in such underwritten offering; and (iii) third, and only if all the securities referred to in clauses (i) and (ii) have been included
in such Registration Statement, shall be allocated pro rata among the officers and directors of the Company that have requested to sell
in such underwritten offering.

(l) 
if the managing underwriter(s) of a proposed underwritten offering of securities effected pursuant to Section 2(e) advise the
Company in writing that, in their opinion, the number of securities requested to be included in such offering exceeds the number which
can be sold in such offering without being likely to have a significant adverse effect on the price, timing or distribution of the securities
offered or the market for the securities offered, the securities to be included in such Registration Statement (i) first, shall be allocated
to any shares that the Company has requested to sell in such underwritten offering, (ii) second, and only if all the securities referred
to in clause (i) have been included in such Registration Statement, shall be allocated, pro rata if necessary, among Holders of Registrable
Securities that have requested to sell in such underwritten offering, and (iii) third, and only if all the securities referred to in
clauses (i) and (ii) have been included in such Registration Statement, shall be allocated pro rata among the holders of all other securities
that have requested to sell in such underwritten offering.

4. Registration
Expenses. All fees and expenses incident to the Company’s performance of or compliance with its obligations under this Agreement
shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement; provided that
Purchaser shall pay to the Company the lesser of (x) the aggregate fees and expenses incident to the Company’s performance of or
compliance with its obligations under this Agreement, or (y) Twenty Thousand Dollars ($20,000), which shall be applied by the Company
toward such fees and expenses. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all
registration and filing fees (including, without limitation, fees and expenses (A) with respect to filings required to be made with the
Commission and any Trading Market on which the Common Stock is then listed for trading, (B) with respect to compliance with applicable
state securities or Blue Sky laws (including, without limitation, fees and disbursements of counsel for the Company in connection with
Blue Sky qualifications or exemptions of the Registrable Securities and determination of the eligibility of the Registrable Securities
for investment under the laws of such jurisdictions as requested by the Holders) and, (ii) printing expenses (including, without limitation,
expenses of printing certificates for Registrable Securities, (iii) messenger, telephone and delivery expenses of the Company, (iv) fees
and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi)
fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by
this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation
of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees
performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing
of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any
underwriting, broker or similar fees, discounts or commissions or stock transfer taxes applicable to any Registered Securities registered
by any Holder or any legal fees or other costs of the Holders. Within ten (10) Trading Days of written notice from the Company, the Holders
shall reimburse the Company for all fees and expenses it incurs hereunder that are otherwise the responsibility of the Holders.

5. Indemnification.

(a) Indemnification
by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify, defend and hold harmless each Holder,
the officers, directors, agents, brokers, general partners, managing members, managers, Affiliates, employees and investment advisers
of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act) and the officers, directors, general partners, managing members, managers, agents, employees and investment advisers of
each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages,
liabilities, costs (including, without limitation, reasonable costs of preparation and investigation and reasonable and documented attorneys’
fees) and expenses (collectively, “Losses”), as incurred, that arise out of or are based upon (i) any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus or any form of prospectus or in any amendment
or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission to state a
material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or form of prospectus
or supplement thereto, in light of the circumstances under which they were made) not misleading, or (ii) any violation or alleged violation
by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection
with the performance of its obligations under this Agreement, except to the extent that such untrue statements, alleged untrue statements,
omissions or alleged omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder
expressly for use therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution
of Registrable Securities, such Prospectus or such form of Prospectus or in any amendment or supplement thereto, related to the use by
a Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing or electronic mail that the Prospectus
is outdated or defective and prior to the receipt by such Holder of the Advice contemplated and defined in Section 7(b) below,
but only if and to the extent that following the receipt of the Advice the misstatement or omission giving rise to such Loss would have
been corrected. The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from
or in connection with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of an Indemnified Party (as defined in Section 5(c)) and
shall survive the transfer of the Registrable Securities by the Holders.

(b) 
Indemnification by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, arising out of or are based upon any untrue or alleged untrue statement
of a material fact contained in any Registration Statement, any Prospectus, or any form of prospectus, or in any amendment or supplement
thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required
to be stated therein or necessary to make the statements therein (in the case of any Prospectus, or any form of prospectus or supplement
thereto, in light of the circumstances under which they were made) not misleading (i) to the extent that such untrue statements or omissions
are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein
or (ii) to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable
Securities, such Prospectus or such form of Prospectus or in any amendment or supplement thereto, to the extent related to the use by
such Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated
or defective and prior to the receipt by such Holder of the Advice contemplated in Section 7(b), but only if and to the extent
that following the receipt of the Advice the misstatement or omission giving rise to such Loss would have been corrected. In no event
shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net proceeds received by such
Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.

(c) 
Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of one counsel reasonably satisfactory to the Indemnified Party and the payment of all reasonable and
documented fees and expenses incurred in connection with defense thereof; provided, that the failure of any Indemnified Party
to give such written notice within a reasonable time of commencement of any such Proceeding shall not relieve the Indemnifying Party
of its obligations or liabilities pursuant to this Agreement, except to the extent that it shall be finally determined by a court of
competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have materially and adversely
prejudiced the Indemnifying Party in its ability to defend such Proceeding.

 An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party
has agreed in writing to pay such fees and expenses; (2) the Indemnifying Party shall have failed promptly to assume the defense of such
Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (3) the named parties to
any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and such Indemnified
Party shall have been advised by counsel that a conflict of interest exists if the same counsel were to represent such Indemnified Party
and the Indemnifying Party; provided, that the Indemnifying Party shall not be liable for the fees and expenses of more than one
separate firm of attorneys at any time for all Indemnified Parties. The Indemnifying Party shall not be liable for any settlement of
any such Proceeding effected without its written consent, which consent shall not be unreasonably withheld, delayed or unreasonably conditioned.
No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding
in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party
from all liability on claims that are the subject matter of such Proceeding.

Subject
to the terms of this Agreement, all documented fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section
5(c)) shall be paid to the Indemnified Party, as incurred, within twenty (20) Trading Days of written notice thereof to the Indemnifying
Party; provided, that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and
expenses applicable to such actions for which such Indemnified Party is finally judicially determined to not be entitled to indemnification
hereunder.

(d) Contribution.
If a claim for indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold
an Indemnified Party harmless for any Losses, then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute
to the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the
relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted
in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified
Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information
supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses
shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other reasonable
fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such
fees or expenses if the indemnification provided for in this Section 5(d) was available to such party in accordance with its terms.

The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by
pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in
the immediately preceding paragraph. Notwithstanding the provisions of this Section 5(d), no Holder shall be required to contribute,
in the aggregate, any amount in excess of the amount by which the net proceeds actually received by such Holder from the sale of the
Registrable Securities subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay
by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such
fraudulent misrepresentation.

6. 
[Intentionally omitted].

7. 
Miscellaneous.

(a) 
Compliance. Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act
as applicable to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant to the Registration
Statement and shall sell the Registrable Securities only in accordance with a method of distribution described in the Registration Statement.

(b) 
Discontinued Disposition. By its acquisition of Registrable Securities, each Holder agrees that, during any Grace Period and upon
receipt of a notice from the Company, such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration
Statement until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus (as
it may have been supplemented or amended) may be resumed. The Company may provide appropriate stop orders to enforce the provisions of
this paragraph.

(c) 
[Intentionally omitted.]

(d) 
Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified
or supplemented, or waived unless the same shall be in writing and signed by the Company and Holders holding at least two-thirds of the
then outstanding Registrable Securities, provided that any party may give a waiver as to itself. Notwithstanding the foregoing, a waiver
or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of Holders and that does
not directly or indirectly affect the rights of other Holders may be given by Holders of all of the Registrable Securities to which such
waiver or consent relates; provided, that the provisions of this sentence may not be amended, modified, or supplemented except
in accordance with the provisions of the immediately preceding sentence. Notwithstanding the foregoing, if any such amendment, modification
or waiver would adversely affect in any material respect any Holder or group of Holders who have comparable rights under this Agreement
disproportionately to the other Holders having such comparable rights, such amendment, modification, or waiver shall also require the
written consent of the Holder(s) so adversely affected.

(e) 
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered
as set forth in the Securities Purchase Agreement.

(f) 
Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. Nothing in this Agreement, express or implied, is intended to confer
upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities
under or by reason of this Agreement, except as expressly provided in this Agreement. The Company may not assign its rights (except by
merger or in connection with another entity acquiring all or substantially all of the Company’s assets) or obligations hereunder
without the prior written consent of all the Holders of the then outstanding Registrable Securities. Notwithstanding anything in this
Agreement to the contrary, Purchaser shall not transfer or assign any of the Registrable Securities, nor any of its rights hereunder,
for a period of six (6) months following the date of this Agreement. Thereafter, Purchaser may (, (i) transfer or assign any of the Registrable
Securities in any sale through underwriters, dealers or agents who sell such Registrable Securities on a national securities exchange,
(iii) transfer or assign any of the Registrable Securities, and (iv) assign its rights hereunder with respect to the Registrable Securities
to its transferees who hold Registrable Securities.

(g) 
Execution and Counterparts. This Agreement may be executed in two or more counterparts, each of which when so executed shall be
deemed to be an original and, all of which taken together shall constitute one and the same Agreement and shall become effective when
counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the
same counterpart. In the event that any signature is delivered by facsimile transmission or in electronic form, such signature shall
create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and
effect as if such facsimile or electronic form were the original thereof.

(h) 
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
determined in accordance with the provisions of the Securities Purchase Agreement.

(i) 
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their good
faith reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.

(j) 
Headings. The headings in this Agreement are for convenience only and shall not limit or otherwise affect the meaning hereof.

(k) 
Independent Nature of Holders’ Obligations and Rights. If and to the extent there is more than one Holder under this Agreement,
the obligations of each Holder hereunder shall be several and not joint with the obligations of any other Holder hereunder, and no Holder
shall be responsible in any way for the performance of the obligations of any other Holder hereunder. Nothing contained herein or in
any other agreement or document delivered at any closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed
to constitute the Holders as a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption
that the Holders are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated
by this Agreement or any other matters, and the Company acknowledges that the Holders are not acting in concert or as a group, and the
Company shall not asset any such claim, with respect to such obligations or transactions. Each Holder shall be entitled to protect and
enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other
Holder to be joined as an additional party in any proceeding for such purpose. It is expressly understood and agreed that each provision
contained in this Agreement is between the Company and a Holder, solely, and not between the Company and the Holders collectively and
not between and among Holders.

(l) Legend.
Each certificate, instrument, or book entry representing any Registrable Securities shall be notated by the Company with a
legend reading substantially as follows:

“THE
SHARES REPRESENTED HEREBY ARE SUBJECT TO A REGISTRATION RIGHTS AGREEMENT, AS MAY BE AMENDED FROM TIME TO TIME, (A COPY OF WHICH MAY BE
OBTAINED UPON WRITTEN REQUEST FROM THE COMPANY), AND BY ACCEPTING ANY INTEREST IN SUCH SHARES THE PERSON ACCEPTING SUCH INTEREST SHALL
BE DEEMED TO AGREE TO AND SHALL BECOME BOUND BY ALL THE PROVISIONS OF THAT REGISTRATION RIGHTS AGREEMENT.” 

 The
Company, by its execution of this Agreement, agrees that it will cause the certificates instruments, or book entry evidencing the Registrable
Securities to be notated with the legend required by this Section 7(l). The parties to this Agreement do hereby agree that the
failure to cause the certificates, instruments, or book entry evidencing the Registrable Securities to be notated with the legend required
by this Section 7(l) shall not affect the validity or enforcement of this Agreement.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK,

SIGNATURE
PAGES TO FOLLOW] 

 

    	 	1	 

     

    

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered by their respective duly authorized
officers as of the date first above written.

 

	“Company”:	 	“Purchases”:
	 	 	 
	CLINIGENCE
  HOLDINGS, INC.	 	APOLLO
  MEDICAL HOLDINGS, INC.
	 	 	 
	 	 	 
	By:
  /s/ Warren Husseinion	 	By:
  /s/ Thomas S. Lam
	Name:
  Warren Husseinion	 	Name:
  Thomas S. Lam, M.D.
	Title:
  Chairman/CEO	 	Co-Chief
  Executive Officer & President
	 	 	 
	Address
  for Notice:		Address
  for Notice:
	2445
  East Sunrise Blvd., Suite 1204	 	1668
  S Garfiel Ave, 2nd Fl.
	Fort
  Lauderdale, FL 33304	 	Alahambra,
  CA 91801
	Attention:
  CEO	 	 

 

 

Registration
Rights Agreement Signature Page

 

    	 	2Exhibit
4.9

AMENDMENT
TO 

REGISTRATION
RIGHTS AGREEMENT

This
Amendment to REGISTRATION RIGHTS Agreement (this “Amendment”)
is entered into and made effective as of July 1, 2022 (“Effective Date”), by and among Nutex Health Inc., a Delaware
corporation (the “Company”) and Thomas T. Vo, in his capacity as the Nutex Representative (as defined below). Each
of the foregoing may be referred to herein as a “Party” and collectively as the “Parties.”

RECITALS

WHEREAS,
the Company and each of the former equityholders (“Equityholders”) of Nutex Health Holdco LLC, a Delaware limited
liability company (“Holdco”), entered into that ‎certain Registration Rights Agreement, dated as of April 1, 2022
(“Registration Rights Agreement”); ‎

WHEREAS,
the Registration Rights Agreement was entered into in connection with the consummation of the transactions contemplated by that certain
Agreement and Plan of Merger, dated as of November 23, 2021, by and among Holdco, Clinigence Holdings, Inc., a Delaware corporation (“Clinigence”),
Nutex Acquisition LLC, a Texas limited liability company (“Merger Sub”), Thomas T. Vo, in his capacity as the representative
of the Holdco Equityholders (“Nutex Representative”), and the other parties listed on the signature pages attached
thereto (the “Merger Agreement”), pursuant to which, among other things, (i) Merger Sub merged with and into Holdco,
with Holdco surviving the merger and becoming a wholly owned subsidiary of Clinigence (the “Merger”), (ii) each Holdco
Equityholder’s equity interests in Holdco immediately converted to the right to receive 3.571428575 shares of Clinigence for each
unit held in Holdco at the time of the Merger (the “Shares”) and (iii) immediately following the Merger, Clinigence
changed its name to Nutex Health Inc.;

WHEREAS,
pursuant to Section 8.1 of the Merger Agreement, the Nutex Representative is authorized to, among other things, amend the Merger
Agreement and all other transaction documents contemplated thereby, including the Registration Rights Agreement on behalf of the Holdco
Equityholders;

WHEREAS,
pursuant to Section 4.9 of the Registration Rights Agreement, the Registration Rights Agreement may be amended by a written agreement
signed by the Company and the Holders holding a majority of the Registrable Securities, where “Holders” means the Holdco
Equityholders and their permitted transferees, and “Registrable Securities” means the Shares issued to each Holdco Equityholder
as a result of the Merger; and

WHEREAS,
in accordance with Section 8.1 of the Merger Agreement and Section 4.9 of the Registration Rights Agreement, the Parties
desire to amend the Registration Rights Agreement, as hereinafter provided; and

WHEREAS,
capitalized terms used herein and not otherwise defined shall have the respective meanings ascribed to them in the Registration Rights
Agreement.

AGREEMENT

NOW,
THEREFORE, in consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Parties hereby agree as follows:

 1. Section 2.1 of the Registration Rights Agreement is hereby amended by adding the following words “‎(with such deadline not to apply if the Company qualifies as a well known seasoned issuer (as defined in Rule 405 of ‎the Securities Act))‎” after the words “Effective Time of the Merger”, to read as follows:

 

“2.1
Resale Registration Statement. As promptly as possible but in no event more than three (3) months following ‎the Effective Time of
the Merger (with such deadline not to apply if the Company qualifies as a well known ‎seasoned issuer (as defined in Rule 405 of
the Securities Act)), the Company shall file with the SEC, or have filed ‎with the SEC, a resale registration statement (the “Resale
Registration Statement”) pursuant to Rule 415 under the ‎Securities Act pursuant to which all of the Registrable Securities
shall be included (on the initial filing or by ‎supplement thereto) to enable the public resale on a delayed or continuous basis
of the Registrable Securities by ‎the Holders. The Company shall file the Resale Registration Statement on such form as the Company
may then ‎utilize under the rules of the SEC and use its commercially reasonable efforts to have such Resale Registration ‎Statement
declared effective under the Securities Act no later than six (6) months following the Effective Time of ‎the Merger. The Company
agrees to use its commercially reasonable efforts to maintain the effectiveness of the ‎Resale Registration Statement, including
by filing any necessary post-effective amendments and prospectus ‎supplements, or, alternatively, by filing new registration statements
relating to the Registrable Securities covered ‎by such Resale Registration Statement as required by Rule 415 under the Securities
Act, continuously until the ‎date that is the earlier of (i) two (2) years following the date of effectiveness of such Resale Registration
‎Statement, or (ii) the date that is the earlier of (A) the date that all Registrable Securities covered by the Resale ‎Registration
Statement may be sold by Holders under Rule 144, and without the requirement for the Company to ‎be in compliance with the current
public information requirements under Rule 144(c)(1) (or Rule 144(i)(2), if ‎applicable) or (B) the date on which the Holders no
longer hold any Registrable Securities‎.

[THE
REMAINDER OF THIS PAGE LEFT BLANK INTENTIONALLY]

    	 	1	 

     

    

‎

IN
WITNESS WHEREOF, the Parties have executed this Amendment as of the Effective Date.

COMPANY:

NUTEX
HEALTH INC.

By:
/s/ Thomas T. Vo

Name:
Thomas T. Vo, M.D.

Title:
Chief Executive Officer

 

NUTEX
REPRESENTATIVE:

/s/
Thomas T. Vo

Thomas
T. Vo, M.D.

    	 	2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]